Polmacoxib
帕马考昔
Report date: 2022/11/25 14:08:32
NME
Base Information
Drug NamePolmacoxib
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in ChinaN/A
Original Approved Country/Territory
Original Approved Date2015/02/05
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesCrystalgenomics Inc
China Registration ClassN/A
Develop Information
Active CompaniesCrystalgenomics Inc
Inactive CompaniesUniversity Of Pennsylvania
Active Indications
Inactive Indications